Literature DB >> 12481011

Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.

Michael H Weinstein1, Sabina Signoretti, Massimo Loda.   

Abstract

Diagnostically reliable identification of prostatic basal cells has depended on staining for high molecular weight cytokeratin. The diagnosis of malignancy is often based on the absence of basal cells. False-negative staining is occasionally observed. Thus, a second method of identifying basal cells might prove useful. Selective expression of p63, a homologue of p53, has been demonstrated in prostatic basal cells. We investigated the diagnostic utility of p63 staining in 70 consecutive specimens for which the differential diagnosis included prostatic adenocarcinoma: 68 needle biopsies and 2 transurethral resection blocks. High molecular weight cytokeratin staining was the gold standard when material was available. A total of 61 specimens were diagnosed as carcinoma, 4 as atrophy, 2 as high-grade prostatic intraepithelial neoplasia, 2 as unclassified collections of benign glands, and 1 as carcinoma versus high-grade prostatic intraepithelial neoplasia. Sections mounted on charged slides were used for p63 staining for 14 specimens. Sections previously hematoxylin and eosin stained on uncharged slides were used for 56 specimens. In every case in which there was successful p63 staining (55 specimens), basal cells in benign lesions were properly marked and other cell types were not stained. Uninformative staining in the remaining 15 specimens was due to failure of tissue adherence in 14 specimens in which sections were on uncharged slides and, in 1 specimen, to poor positive internal control staining of benign glands. Thus, p63 staining was informative in 55 of 56 specimens (98%) for which there was material for examination. No case with satisfactory p63 and high molecular weight staining showed disagreement between the two stains. An additional group of 21 transurethral resection specimens was stained (p63 and high molecular weight cytokeratin). There was less false-negative staining for p63 compared with the case of high molecular weight cytokeratin. No false-positive staining was seen. We conclude that p63 staining is at least as sensitive and specific for the identification of basal cells in diagnostic prostate specimens as is high molecular weight cytokeratin staining.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12481011     DOI: 10.1097/01.MP.0000038460.95912.6E

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  24 in total

1.  Modulation of TGF-β-inducible hypermotility by EGF and other factors in human prostate epithelial cells and keratinocytes.

Authors:  Wei Wei; Patricia D Barron; James G Rheinwald
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-11-02       Impact factor: 2.416

Review 2.  [Differential diagnosis of prostate cancer: impact of pattern analysis and immunohistochemistry].

Authors:  H Bonkhoff
Journal:  Pathologe       Date:  2005-11       Impact factor: 1.011

3.  Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients.

Authors:  Anita Kloss-Brandstätter; Georg Schäfer; Gertraud Erhart; Alexander Hüttenhofer; Stefan Coassin; Christof Seifarth; Monika Summerer; Jasmin Bektic; Helmut Klocker; Florian Kronenberg
Journal:  Am J Hum Genet       Date:  2010-12-10       Impact factor: 11.025

4.  Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots.

Authors:  Jian Liu; Stephen K Lau; Vijay A Varma; Richard A Moffitt; Matthew Caldwell; Tao Liu; Andrew N Young; John A Petros; Adeboye O Osunkoya; Tracey Krogstad; Brian Leyland-Jones; May D Wang; Shuming Nie
Journal:  ACS Nano       Date:  2010-05-25       Impact factor: 15.881

5.  Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development.

Authors:  Daniel T Johnson; Richard Luong; Suk Hyung Lee; Yue Peng; Atossa Shaltouki; Jane T Lee; Dong Lin; Yuzhuo Wang; Zijie Sun
Journal:  J Biol Chem       Date:  2012-12-28       Impact factor: 5.157

6.  Periacinar retraction clefting and d2-40 expression in prostatic adenocarcinoma.

Authors:  Monika Ulamec; Tihana Džombeta; Hrvoje Cupić; Tanja Leniček; Davor Tomas; Božo Krušlin
Journal:  Pathol Oncol Res       Date:  2011-09-13       Impact factor: 3.201

7.  Periacinar Clefting and p63 Immunostaining in Prostatic Intraepithelial Neoplasia and Prostatic Carcinoma.

Authors:  Bozo Kruslin; Davor Tomas; Aida Cviko; Hrvoje Cupic; Ljubica Odak; Mladen Belicza
Journal:  Pathol Oncol Res       Date:  2006-12-25       Impact factor: 3.201

8.  miR-205 regulates basement membrane deposition in human prostate: implications for cancer development.

Authors:  P Gandellini; V Profumo; A Casamichele; N Fenderico; S Borrelli; G Petrovich; G Santilli; M Callari; M Colecchia; S Pozzi; M De Cesare; M Folini; R Valdagni; R Mantovani; N Zaffaroni
Journal:  Cell Death Differ       Date:  2012-05-04       Impact factor: 15.828

9.  Irs2 inactivation suppresses tumor progression in Pten+/- mice.

Authors:  Matthias Szabolcs; Megan Keniry; Laura Simpson; Latarsha J Reid; Susan Koujak; Sarah C Schiff; Giselle Davidian; Scott Licata; Sofia Gruvberger-Saal; Vundavalli V V S Murty; Subhadra Nandula; Argiris Efstratiadis; Jake A Kushner; Morris F White; Ramon Parsons
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

10.  Characterisation of the proximal airway squamous metaplasia induced by chronic tobacco smoke exposure in spontaneously hypertensive rats.

Authors:  Sarah J Bolton; Kate Pinnion; Victor Oreffo; Martyn Foster; Kent E Pinkerton
Journal:  Respir Res       Date:  2009-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.